ifosfamide has been researched along with Invasiveness, Neoplasm in 40 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This randomized prospective multicenter phase III trial was designed to compare progression-free survival of patients with advanced soft tissue sarcoma receiving either regimen of standard doxorubicin 75 mg/m2 every 21 days, ifosfamide 9 g/m2 over 3 days continuous infusion, or ifosfamide 3 g/m2 per day in 3 hours over 3 days." | 9.12 | Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. ( Blay, JY; Hogendoorn, PC; Kirkpatrick, A; Le Cesne, A; Leahy, MG; Lorigan, P; Papai, Z; Radford, JA; Rodenhuis, S; Van Glabbeke, MM; Verweij, J, 2007) |
| "To evaluate single-agent ifosfamide in the treatment of invasive thymoma." | 7.70 | Treatment of invasive thymoma with single-agent ifosfamide. ( Bryant, B; Dussek, J; Harper, PG; Highley, MS; Hodson, N; Hughes, J; Karapetis, C; Parnis, FX; Rankin, E; Rowland, C; Underhill, CR, 1999) |
| "Osteosarcoma is the first primary malignant bone tumor, characterized by a complex genetic and resistance to conventional treatments." | 5.37 | Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response. ( Alberti, L; Besse, A; Blay, JY; Duc, A; Dutour, A; Gougelet, A; Perez, J; Pissaloux, D, 2011) |
| "This randomized prospective multicenter phase III trial was designed to compare progression-free survival of patients with advanced soft tissue sarcoma receiving either regimen of standard doxorubicin 75 mg/m2 every 21 days, ifosfamide 9 g/m2 over 3 days continuous infusion, or ifosfamide 3 g/m2 per day in 3 hours over 3 days." | 5.12 | Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. ( Blay, JY; Hogendoorn, PC; Kirkpatrick, A; Le Cesne, A; Leahy, MG; Lorigan, P; Papai, Z; Radford, JA; Rodenhuis, S; Van Glabbeke, MM; Verweij, J, 2007) |
| "Doxorubicin-based chemotherapy does not appear to offer a survival benefit to patients who have high-risk primary extremity soft tissue sarcomas, whereas ifosfamide-based chemotherapy does." | 4.83 | Advances in chemotherapy for patients with extremity soft tissue sarcoma. ( Eckardt, JJ; Eilber, FC; Eilber, FR; Nelson, SD; Tap, WD, 2006) |
| "We reviewed the records of 50 patients with osteosarcoma who underwent marginal resection following effective preoperative chemotherapy; 18 were treated with the MMIA (high-dose methotrexate (HD-MTX), adriamycin (ADR), ifosfamide (IFO)) and cisplatin (DDP), and 32 patients were treated with the DIA (DDP, ADR and IFO)." | 3.80 | Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes. ( Xu, M; Xu, S; Yu, X, 2014) |
| "To evaluate single-agent ifosfamide in the treatment of invasive thymoma." | 3.70 | Treatment of invasive thymoma with single-agent ifosfamide. ( Bryant, B; Dussek, J; Harper, PG; Highley, MS; Hodson, N; Hughes, J; Karapetis, C; Parnis, FX; Rankin, E; Rowland, C; Underhill, CR, 1999) |
| "While most invasive primary breast cancers are epithelial derived adenocarcinomas, rare neoplasms such as the phyllodes tumor may arise from mesenchymal tissue." | 2.49 | Unusual aggressive breast cancer: metastatic malignant phyllodes tumor. ( Singer, A; Tresley, J; Velazquez-Vega, J; Yepes, M, 2013) |
| "Brain metastases are rare in the natural history of Wilms tumor." | 2.41 | Brain metastases in Wilms' tumor: case report and literature review. ( Grimard, L; Halton, JM; Hsu, E; MacRae, R; Nizalik, E, 2002) |
| "Mediastinal angiosarcoma is a rare intrathoracic tumour and the therapeutic approach remains poorly codified." | 1.38 | [A case of mediastinal angiosarcoma]. ( Aubert, M; Coudurier, M; Deroux, A; Destors, M; Girard, N; Lantuejoul, S; Moro-Sibilot, D, 2012) |
| "High-risk soft tissue sarcoma was defined as high-grade malignancy and at least two of the following criteria: size≥8 cm, vascular invasion, or necrosis." | 1.37 | Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall. ( Bruland, ØS; Engellau, J; Eriksson, M; Folin, A; Hall, KS; Jebsen, NL; Trovik, CS; Turesson, I, 2011) |
| "Osteosarcoma is the first primary malignant bone tumor, characterized by a complex genetic and resistance to conventional treatments." | 1.37 | Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response. ( Alberti, L; Besse, A; Blay, JY; Duc, A; Dutour, A; Gougelet, A; Perez, J; Pissaloux, D, 2011) |
| "Angiosarcoma is a rare neoplasm, accounting for only 1%-2% of all sarcomas." | 1.37 | Radically resected epithelioid angiosarcoma that originated in the mediastinum. ( Nakai, R; Tanaka, Y; Tane, S; Tauchi, S; Uchino, K; Yoshimura, M, 2011) |
| "Retinoblastoma is a malignant tumor of the embryonic neural retina." | 1.34 | Retinoblastoma in children older than 5 years of age. ( Antoneli, CB; Arias, V; Castilho, MS; Chojniak, MM; de Aguirre Neto, JC; Novaes, PE; Ribeiro, KB, 2007) |
| "The efficacy of CHOP regimen on Burkitt's lymphoma is poor." | 1.34 | [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents]. ( Chen, XQ; Guan, ZZ; He, YJ; Lin, H; Ling, JY; Liu, DG; Luo, WB; Sun, XF; Xia, Y; Xiang, XJ; Zhen, ZJ; Zheng, L, 2007) |
| "Ewing sarcoma is a relatively uncommon malignant bone neoplasm that usually occurs in children and young adults and involves the major long bones, pelvis, and ribs." | 1.32 | Extraskeletal Ewing sarcoma of the diaphragm presenting with hemothorax. ( Alper, F; Eroğlu, A; Gündoğdu, C; Karaoğlanoğlu, N; Kürkçüoğlu, IC, 2004) |
| "For giant testicular tumor with extensive invasion to the spermatic cord, initial chemotherapy followed by surgical resection appears to be a better management." | 1.30 | [Two cases of giant testicular tumor with widespread extension to the spermatic cord: usefulness of upfront chemotherapy]. ( Fukui, I; Izutani, T; Kin, T; Kitsukawa, S; Maeda, Y; Shishido, T; Yonese, J, 1999) |
| "We report a rare case of adult T cell leukemia/lymphoma (ATLL) in which cardiac invasion was clinically demonstrated and treated effectively." | 1.28 | [Cardiac invasion of ATLL cells and therapeutic effects of local along with systemic treatments]. ( Imoto, S; Ito, M; Nakagawa, T, 1989) |
| " With future identification of effective chemotherapy, new studies may be focused upon patients with localized disease to reduce radiation dosage or the need for immediate surgical resection of all involved eyes." | 1.27 | The use of chemotherapy for extraocular retinoblastoma. ( Crom, DB; Howarth, C; Pratt, CB, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.00) | 18.7374 |
| 1990's | 7 (17.50) | 18.2507 |
| 2000's | 15 (37.50) | 29.6817 |
| 2010's | 16 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singer, A | 1 |
| Tresley, J | 1 |
| Velazquez-Vega, J | 1 |
| Yepes, M | 1 |
| Hildyard, C | 1 |
| Sheikh, S | 1 |
| Eyre, T | 1 |
| Collins, G | 1 |
| Sueoka, K | 1 |
| Umayahara, K | 1 |
| Abe, A | 1 |
| Usami, T | 1 |
| Yamamoto, A | 1 |
| Nomura, H | 1 |
| Matoda, M | 1 |
| Okamoto, S | 1 |
| Omatsu, K | 1 |
| Kondo, E | 1 |
| Kato, K | 1 |
| Takeshima, N | 1 |
| Xu, M | 1 |
| Xu, S | 1 |
| Yu, X | 1 |
| Nieto, Y | 1 |
| Tu, SM | 1 |
| Bassett, R | 1 |
| Jones, RB | 1 |
| Gulbis, AM | 1 |
| Tannir, N | 1 |
| Kingham, A | 1 |
| Ledesma, C | 1 |
| Margolin, K | 1 |
| Holmberg, L | 1 |
| Champlin, R | 1 |
| Pagliaro, L | 1 |
| Tsukamoto, S | 1 |
| Kurematsu, Y | 1 |
| Honoki, K | 1 |
| Kido, A | 1 |
| Somekawa, S | 1 |
| Kaya, D | 1 |
| Sadamitsu, T | 1 |
| Fukui, H | 1 |
| Tanaka, Y | 2 |
| Milowsky, MI | 1 |
| Nanus, DM | 1 |
| Maluf, FC | 1 |
| Mironov, S | 2 |
| Shi, W | 1 |
| Iasonos, A | 2 |
| Riches, J | 1 |
| Regazzi, A | 1 |
| Bajorin, DF | 2 |
| Saba, NF | 1 |
| Choi, M | 1 |
| Muller, S | 1 |
| Shin, HJ | 1 |
| Tighiouart, M | 1 |
| Papadimitrakopoulou, VA | 1 |
| El-Naggar, AK | 1 |
| Khuri, FR | 1 |
| Chen, ZG | 1 |
| Shin, DM | 1 |
| Jebsen, NL | 1 |
| Bruland, ØS | 1 |
| Eriksson, M | 1 |
| Engellau, J | 1 |
| Turesson, I | 1 |
| Folin, A | 1 |
| Trovik, CS | 1 |
| Hall, KS | 1 |
| Gougelet, A | 1 |
| Pissaloux, D | 1 |
| Besse, A | 1 |
| Perez, J | 1 |
| Duc, A | 1 |
| Dutour, A | 1 |
| Blay, JY | 2 |
| Alberti, L | 1 |
| Patrelli, TS | 1 |
| Gizzo, S | 1 |
| Di Gangi, S | 1 |
| Guidi, G | 1 |
| Rondinelli, M | 1 |
| Nardelli, GB | 1 |
| Tane, S | 1 |
| Tauchi, S | 1 |
| Uchino, K | 1 |
| Nakai, R | 1 |
| Yoshimura, M | 1 |
| Wang, Y | 1 |
| Wang, G | 1 |
| Wei, LH | 1 |
| Huang, LH | 1 |
| Wang, JL | 1 |
| Wang, SJ | 1 |
| Li, XP | 1 |
| Shen, DH | 1 |
| Bao, DM | 1 |
| Gao, J | 1 |
| Gong, L | 1 |
| Lou, JY | 1 |
| Wang, P | 1 |
| Zhang, JW | 1 |
| Liu, H | 1 |
| Peng, ZL | 1 |
| Ouadnouni, Y | 1 |
| Smahi, M | 1 |
| Bouchikh, M | 1 |
| Achir, A | 1 |
| Msougar, Y | 1 |
| Lakranbi, M | 1 |
| Benosman, A | 1 |
| Krege, S | 1 |
| Vitobello, D | 1 |
| Siesto, G | 1 |
| Pirovano, C | 1 |
| Ieda, N | 1 |
| Deroux, A | 1 |
| Destors, M | 1 |
| Coudurier, M | 1 |
| Lantuejoul, S | 1 |
| Aubert, M | 1 |
| Girard, N | 1 |
| Moro-Sibilot, D | 1 |
| Fahn, W | 1 |
| Schlemmer, M | 1 |
| Issels, R | 1 |
| Uberfuhr, P | 1 |
| Reichart, B | 1 |
| Ohata, N | 1 |
| Ozaki, T | 1 |
| Kunisada, T | 1 |
| Morimoto, Y | 1 |
| Tanaka, M | 1 |
| Inoue, H | 1 |
| Eroğlu, A | 1 |
| Kürkçüoğlu, IC | 1 |
| Karaoğlanoğlu, N | 1 |
| Alper, F | 1 |
| Gündoğdu, C | 1 |
| Kawaguchi, T | 1 |
| Kumabe, T | 1 |
| Watanabe, M | 1 |
| Tominaga, T | 1 |
| Nomura, E | 1 |
| Isoda, K | 1 |
| Yamanaka, K | 1 |
| Yamaguchi, M | 1 |
| Hakamada, A | 1 |
| Mizutani, H | 1 |
| Eilber, FC | 1 |
| Tap, WD | 1 |
| Nelson, SD | 1 |
| Eckardt, JJ | 1 |
| Eilber, FR | 1 |
| de Aguirre Neto, JC | 1 |
| Antoneli, CB | 1 |
| Ribeiro, KB | 1 |
| Castilho, MS | 1 |
| Novaes, PE | 1 |
| Chojniak, MM | 1 |
| Arias, V | 1 |
| Galsky, MD | 1 |
| Scattergood, J | 1 |
| Donat, SM | 1 |
| Bochner, BH | 1 |
| Herr, HW | 1 |
| Russo, P | 1 |
| Boyle, MG | 1 |
| Lorigan, P | 1 |
| Verweij, J | 1 |
| Papai, Z | 1 |
| Rodenhuis, S | 1 |
| Le Cesne, A | 1 |
| Leahy, MG | 1 |
| Radford, JA | 1 |
| Van Glabbeke, MM | 1 |
| Kirkpatrick, A | 1 |
| Hogendoorn, PC | 1 |
| Sun, XF | 1 |
| Zhen, ZJ | 1 |
| Liu, DG | 1 |
| Xia, Y | 1 |
| Xiang, XJ | 1 |
| Chen, XQ | 1 |
| Ling, JY | 1 |
| Zheng, L | 1 |
| Luo, WB | 1 |
| Lin, H | 1 |
| He, YJ | 1 |
| Guan, ZZ | 1 |
| Bui, NB | 1 |
| Stöckle, E | 1 |
| Coindre, JM | 1 |
| Kantor, G | 1 |
| Kind, M | 1 |
| Thomas, L | 1 |
| Bolis, G | 1 |
| van Zainten-Przybysz, I | 1 |
| Scarfone, G | 1 |
| Zanaboni, F | 1 |
| Scarabelli, C | 1 |
| Tateo, S | 1 |
| Calabrese, M | 1 |
| Parazzini, F | 1 |
| Iwasaki, Y | 1 |
| Kubota, Y | 1 |
| Yokomura, I | 1 |
| Ueda, M | 1 |
| Hashimoto, S | 1 |
| Arimoto, T | 1 |
| Inaba, T | 1 |
| Shimazaki, C | 1 |
| Nakagawa, M | 1 |
| Toda, S | 1 |
| Kitsukawa, S | 2 |
| Kinn, T | 1 |
| Yoshida, T | 1 |
| Yonese, J | 2 |
| Izutami, T | 1 |
| Fukui, I | 2 |
| Ishikawa, Y | 1 |
| Kin, T | 1 |
| Shishido, T | 1 |
| Maeda, Y | 1 |
| Izutani, T | 1 |
| Highley, MS | 1 |
| Underhill, CR | 1 |
| Parnis, FX | 1 |
| Karapetis, C | 1 |
| Rankin, E | 1 |
| Dussek, J | 1 |
| Bryant, B | 1 |
| Rowland, C | 1 |
| Hodson, N | 1 |
| Hughes, J | 1 |
| Harper, PG | 1 |
| van de Wetering, MD | 1 |
| Peper, JA | 1 |
| Hanna, A | 1 |
| Edan, C | 1 |
| Heresbach, N | 1 |
| Guegan, Y | 1 |
| MacRae, R | 1 |
| Grimard, L | 1 |
| Hsu, E | 1 |
| Nizalik, E | 1 |
| Halton, JM | 1 |
| Buxton, EJ | 1 |
| Saunders, N | 1 |
| Blackledge, GR | 1 |
| Kelly, K | 1 |
| Redman, CW | 1 |
| Monaghan, J | 1 |
| Paterson, ME | 1 |
| Luesley, DM | 1 |
| Imoto, S | 1 |
| Nakagawa, T | 1 |
| Ito, M | 1 |
| Pratt, CB | 1 |
| Crom, DB | 1 |
| Howarth, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors[NCT00936936] | Phase 2 | 64 participants (Actual) | Interventional | 2009-06-02 | Active, not recruiting | ||
| Phase I/II Trial of Sequential Doxorubicin/Gemcitabine (AG) and Ifosfamide, Paclitaxel, and Cisplatin (ITP) Chemotherapy (AG-ITP) in Patients With Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium[NCT00003105] | Phase 1/Phase 2 | 30 participants (Anticipated) | Interventional | 1997-09-30 | Completed | ||
| Randomized Phase III Trial of Two Investigational Schedules of Ifosfamide vs. Standard Dose Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma[NCT00003212] | Phase 3 | 780 participants (Anticipated) | Interventional | 1998-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for ifosfamide and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Unusual aggressive breast cancer: metastatic malignant phyllodes tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Deoxycytidi | 2013 |
Cervical Mullerian adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature.
Topics: Adenosarcoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Chemotherapy, Adju | 2011 |
[PEB treatment of testicular cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Combin | 2012 |
Advances in chemotherapy for patients with extremity soft tissue sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Dose-Response Rela | 2006 |
[Locally developed sarcoma of the thoracic wall].
Topics: Antineoplastic Combined Chemotherapy Protocols; Back; Chemotherapy, Adjuvant; Combined Modality Ther | 1996 |
[Successful multidisciplinary treatment for bladder cancer with priapism. A case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Comb | 1998 |
Brain metastases in Wilms' tumor: case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Ther | 2002 |
4 trials available for ifosfamide and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin | 2009 |
Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biop | 2007 |
Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dose-Respon | 2007 |
Determinants of response to a cisplatin-based regimen as neoadjuvant chemotherapy in stage IB-IIB invasive cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined M | 1996 |
29 other studies available for ifosfamide and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Cerebrospinal Fluid | 2013 |
Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin | 2015 |
Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; | 2014 |
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; C | 2015 |
Severe toxicity of chemotherapy against advanced soft tissue sarcoma in Werner's syndrome: Ifosfamide-induced encephalopathy with central diabetes insipidus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Diabetes Insipidus, Neurogenic; Doxo | 2016 |
Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Case-Control | 2009 |
Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Ex | 2011 |
Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Disease Models, Animal | 2011 |
Radically resected epithelioid angiosarcoma that originated in the mediastinum.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, Adjuvant; Doxorubicin; | 2011 |
Neoadjuvant chemotherapy for locally advanced cervical cancer reduces surgical risks and lymph-vascular space involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplati | 2011 |
Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 2012 |
[A rare tumor of the chest wall: the synovial sarcoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chest Pain; Comb | 2011 |
Surgical outcomes of robotic radical hysterectomy after neoadjuvant chemotherapy for locally advanced cervical cancer: comparison with early stage disease.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinom | 2013 |
[A case of mediastinal angiosarcoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chest Pain; Doxorubicin; Dyspnea; Fema | 2012 |
[Leiomyosarcoma of the heart--interdisciplinary therapeutic approach of systemic chemotherapy and subsequent heart transplantation].
Topics: Adult; Antineoplastic Agents; Combined Modality Therapy; Doxorubicin; Fatal Outcome; Heart Atria; He | 2003 |
Extended total sacrectomy and reconstruction for sacral tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combi | 2004 |
Extraskeletal Ewing sarcoma of the diaphragm presenting with hemothorax.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Combined Modality The | 2004 |
Atypical teratoid/rhabdoid tumour with leptomeningeal dissemination in an adult.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Combined Mod | 2004 |
Extra nodal NK/T-cell lymphoma nasal type that responded to DeVIC combination chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Combined Modality | 2005 |
Retinoblastoma in children older than 5 years of age.
Topics: Age Distribution; Antineoplastic Combined Chemotherapy Protocols; Brazil; Chemotherapy, Adjuvant; Ch | 2007 |
[Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, P | 2007 |
[Invasive thymoma successfully treated with high-dose chemotherapy followed by peripheral blood stem cell transplantation(PBSCT)].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality The | 1998 |
[Two cases of giant testicular tumor with widespread extension to the spermatic cord: usefulness of upfront chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposi | 1999 |
Treatment of invasive thymoma with single-agent ifosfamide.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Female; Humans; Ifosfamide; Male; Middle Aged; Neopl | 1999 |
Adult respiratory distress syndrome (ARDS) after chemotherapy.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Diagnosis, Differential; Fatal Outcome; Female; Human | 2000 |
[Expanding mature pineal teratoma syndrome. Case report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cerebrospinal Fluid S | 2000 |
The potential for adjuvant therapy in early-stage cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; B | 1990 |
[Cardiac invasion of ATLL cells and therapeutic effects of local along with systemic treatments].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Heart Neoplasms; Humans; Ifosfami | 1989 |
The use of chemotherapy for extraocular retinoblastoma.
Topics: Bone Marrow Diseases; Brain Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Evaluation; Eye Ne | 1985 |